Inyx Inc IYXI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $5,310.67
- Volume/Avg
- 7,801 / 7,801
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Inyx Inc is focused on the development, manufacture, and marketing of prescription and over-the-counter aerosol products and drug delivery technologies for the treatment of respiratory, allergy, cardiovascular and dermatological, and topical conditions.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 572
- Website
- —
Valuation
|
Metric
|
IYXI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IYXI
|
|---|---|
Quick Ratio | 0.16 |
Current Ratio | 0.26 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
IYXI
|
|---|---|
Return on Assets (Normalized) | −36.26% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −55.66% |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Npnwzlqrq | Mtvsr | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Pkljwzvzd | Qtxq | $68.9 Bil | |
HLN
| Haleon PLC ADR | Yfmtbxvc | Dqjm | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xxhnqlfyn | Vvxg | $14.7 Bil | |
VTRS
| Viatris Inc | Mlhjyrfq | Vkf | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hqbytbmsp | Mgzy | $11.9 Bil | |
CTLT
| Catalent Inc | Spmmrjmr | Lstpsv | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Xjxzlkzj | Cnrp | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Ydkvftbmf | Jhtvv | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pfvcjxdp | Tnthpz | $3.5 Bil |